Second-Line Chemotherapy for Advanced Non-small Cell Lung Cancer: Past, Present, and Hope for the Future

Keunchil Park

doi:10.4143/crt.2003.35.4.279

Articles

Page Path: HOME > Cancer Res Treat > Volume 35(4); 2003 > Article

Second-Line Chemotherapy for Advanced Non-small Cell Lung Cancer: Past, Present, and Hope for the Future: Keunchil Park; Cancer Research and Treatment 2003;35(4): 279-280.
DOI: https://doi.org/10.4143/crt.2003.35.4.279
Published online: August 31, 2003

Division of Hematology and Oncology, Department of Medicine,Samsung Medical Center, Sungkyunkwan University School ofMedicine, Seoul, Korea.

3,474 Views
15 Download
4 Crossref
0 Scopus

Full Article

Download PDF

Abstract

No abstract available.

Figure & Data

References

Citations

Citations to this article as recorded by

Positive expression of ERCC1 predicts a poorer platinum-based treatment outcome in Chinese patients with advanced non-small-cell lung cancer
Xin Wang, Jun Zhao, Lu Yang, Li Mao, Tongtong An, Hua Bai, Shuhang Wang, Xuyi Liu, Guoshuang Feng, Jie Wang
Medical Oncology.2010; 27(2): 484. CrossRef
Clinical Significance of Vascular Endothelial Growth Factors (VEGF)-C and -D in Resected Non-Small Cell Lung Cancer
Yoon Ho Ko, Chan-Kwon Jung, Myung-Ah Lee, Jae Ho Byun, Jin Hyoung Kang, Kyo Young Lee, Keon Hyun Jo, Young Pil Wang, Young Seon Hong
Cancer Research and Treatment.2008; 40(3): 133. CrossRef
Gefitinib (ZD1839): Therapy in selected patients with non-small cell lung cancer (NSCLC)?
Diego Dongiovanni, Lorenzo Daniele, Carla Barone, Vincenzo Dongiovanni, Camilla Fissore, Anna Sapino, Luigia Macrì, Giovanni Bussolati, Lucio Buffoni, Fabio Gaspari, Raffaella Grillo, Nadia Birocco, Alfredo Addeo, Libero Ciuffreda, Marina Schena
Lung Cancer.2008; 61(1): 73. CrossRef
Gefitinib (ZD1839) Monotherapy as a Salvage Regimen for Previously Treated Advanced Non-Small Cell Lung Cancer
Jinny Park, Byung Bae Park, Jee Youn Kim, Se-Hoon Lee, Soon Il Lee, Ho Young Kim, Jung Han Kim, Se Hoon Park, Kyung-Eun Lee, Joon Oh Park, Kihyun Kim, Chul Won Jung, Young Suk Park, Young-Hyuck Im, Won Ki Kang, Mark H. Lee, Keunchil Park
Clinical Cancer Research.2004; 10(13): 4383. CrossRef

Cite

CITE: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Second-Line Chemotherapy for Advanced Non-small Cell Lung Cancer: Past, Present, and Hope for the Future

Cancer Res Treat. 2003;35(4):279-280. Published online August 31, 2003

DOI: https://doi.org/10.4143/crt.2003.35.4.279

Related articles

First-Line Alectinib vs. Brigatinib in Advanced Non–Small Cell Lung Cancer with ALK Rearrangement: Real-World Data